- March 13, 2024
- Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Launches Solmack® Q-Arl D, Chewable Tablets for Diarrhea Caused by Overeating and Overdrinking that Can Be Taken Anywhere Without Water - A New Addition to the Solmack Product Line
Taiho Pharmaceutical Co., Ltd. announced that it launched Solmack® Q-Arl D, a designated second-class OTC drug, in pharmacies and drugstores throughout Japan today, March 13, 2024. Solmack Q-Arl1 D is effective for diarrhea caused by overeating and overdrinking as well as diarrhea caused by getting chilled while asleep.
Solmack Q-Arl D
The Solmack series has steadfastly addressed issues such as the nausea caused by overeating, overdrinking, hangovers, and other unpleasant aftereffects of drinking too much for over four decades since its launch in 1979.
Solmack Q-Arl D is the second product in the Q-Arl series within the Solmack brand lineup, following Solmack Q-Arl S. Solmack Q-Arl D contains the antidiarrheal ingredient Loperamide Hydrochloride, the digestive enzyme Biodiastase 2000, and Lactomin, a type of lactic acid bacteria. These three active ingredients are effective for the symptoms of diarrhea.
According to a 2021 in-house survey of alcohol consumers2, the symptoms people associate with drinking alcohol were thirst (25.1%), flushed face/body (23.6%), headache (23.5%), body bloating (16.4%), and memory impairment (15.8%), followed by diarrhea (loose bowels, soft stool, etc.) at 15.7%. Additionally, when asked about symptoms actually experienced in the past year, diarrhea (loose bowels, soft stool, etc.) ranked highest, at 22.1%, indicating about one in five people had this experience. Solmack Q-Arl D supports people in such situations. The symptoms of diarrhea caused by overeating and overdrinking can occur anywhere. Since Solmack Q-Arl D comes in easy-to-take chewable tablets that can be taken without water, it provides convenient relief whenever and wherever diarrhea associated with overeating and overdrinking strikes.
Taiho Pharmaceutical will continue to create a chain of “smiles” by exploring people’s true needs and creating innovative products to meet such needs.
1 “Q-Arl” is a coined term combining “cure” and “alcohol.”
2 In-house survey
Survey entity: Taiho Pharmaceutical Co., Ltd.
Survey conducted by: Intage Healthcare Inc.
Survey period: April 2021
Sample size: 6,696 people (from a total of 10,099 screened, targeting respondents who drink alcohol at least once a year)
Survey method: Online questionnaire
Product Features
- Contains three active ingredients that are effective for symptoms of diarrhea: Loperamide Hydrochloride, the digestive enzyme Biodiastase 2000, and lactic acid bacteria Lactomin
- Comes in easy-to-take chewable tablets that can be taken without water
Product Overview
|
Brand name |
Solmack® Q-Arl D |
|
Risk category |
Designated second-class OTC drug |
|
Active ingredients (1 day’s dose / 4 tablets) |
Loperamide Hydrochloride: 1 mg Biodiastase 2000: 90 mg Lactomin (Enterococcus faecalis): 20 mg |
|
Dosage and administration |
Chew or dissolve the following amount in the mouth. Discontinue use once diarrhea stops. Allow at least 4 hours between doses. Adults (15 years or older): Take two tablets, twice a day. Under 15 years old: Do not take. |
|
Indications |
Diarrhea caused by overeating/overdrinking, and diarrhea caused by getting chilled while asleep |
|
Suggested retail price |
12 tablets (6 doses): JPY 1,320 yen (1,200 excluding tax) |
|
Launch date |
March 13, 2024 |
|
Manufacturer |
Daisho Pharmaceutical Co., Ltd. |
|
Distributor |
Taiho Pharmaceutical Co., Ltd. |
This drug should only be used after consulting with a pharmacist or registered salesperson and carefully reading the precautions for use.
Information in this news release was current as of the original release date.
Taiho Pharmaceutical's press releases may contain information about prescription drugs including products currently under development, however information contained in the press releases are not intended to constitute promotion, advertisement, or medical advice.